Skip to content

A Clinical trial of Mashadi Avapeedana & Mashadi Taila Nasya(transnasal route) in Paralysis(Pakshaghata) with special reference to ischemic stroke

Randomized Comparative Clinical Study To Evaluate The Effect Of Mashadi Avapeedana with Mashadi Taila Nasya In Pakshaghata With Special Reference To Ischemic Stroke - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/055084
Enrollment
40
Registered
2023-07-11
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G968- Other specified disorders of central nervous system

Interventions

None listed

Sponsors

Dr Vishalavva N Iranagoudra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with chesta Nivrutti of Vama or Dakshina Parshwa, Ardhakaya Karmahani, Vaksanga, Suptata of Hasta and Pada. Subjects suffering from ischemic stroke without any severe complications. subjects of either sex. subjects of age group 30-70 years. Stable subjects upto 2 years chronicity of ischemic strokes are included. Subjects fit for Avapeedana Nasya and Taila Nasya. Subjects of acute stroke are taken for study once fit for Avapeedana Nasya and Taila Nasya.

Exclusion criteria

Exclusion criteria: Subjects who are Disoriented and Unconscious. Uncontrolled Diabetic and Hpertensive. Intracranial infections like Meningitis, Encephalitis etc. Post traumatic Pakshaghata. Haemorrhagic stroke. Space occupying lesions of Brain such as tumours. Congenital defects such as Diffuse Sclerosis, Cerebral agenesis etc and other major illness. Subjects who are suffering with CKD, AKD, CCF & IHD.

Design outcomes

Primary

MeasureTime frame
Improvements in cardinal signs & symptoms like Cheshta Nivrutti of Vama or Dakshina Parshwa Ardhakaya Karmahani Vaksanga Suptata in Hasta and PadaTimepoint: 0th day 8th day and 24 days

Secondary

MeasureTime frame
Improvement Noticed on clinical features through National institutes of Health & National institute of Neurological disorder & Stroke Rankins disability scale Modified Barthel IndexTimepoint: 0th day 8th days & 24th day

Countries

India

Contacts

Public ContactDr Vishalavva N Iranagoudra

D G M Ayurvedic Medical College Hospital and PG and PhD studies Gadag

jairajpb111@gmail.com9448516176

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026